CYRX - クリオポ―ト （CryoPort Inc.） クリオポ―トCYRXのチャート
CYRXの企業情報
| symbol | CYRx |
|---|---|
| 会社名 | CryoPort Inc （クリオポ―ト） |
| 分野（sector） | Transportation ヘルスケア |
| 産業（industry） | Oil Refining/Marketing |
| 業種 | 海運貨物_物流 IT・通信（IT_Communications） |
| 概要 | 事業概要 Cryoport Inc. (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials such as immunotherapies stem cells chimeric antigen receptors (CAR)-T cells and reproductive cells for clients. The Company's Cryoport Express Solution includes a cloud-based logistics operating platform which is branded as the Cryoportal. The Company's Cryoport Express Solutions are made up of the Cryoportal software platform Cryoport Express Shippers Cryoport Express Smart Pak data loggers and its life sciences cold chain logistics expertise. The Cryoportal is used by the Company its clients and its business partners to automate the entry of orders prepare customs documentation and to facilitate status and location monitoring of shipped orders while in transit. クリオポ―トは米国の医療施設向け冷凍輸送サ―ビス企業。幹細胞(ステムセル)研究所、病理診断研究所、バイオ医薬品企業、体外受精施設、ワクチン製造メ―カ―や畜産企業に対し、冷凍輸送ソリュ―ションを提供する。また、輸送の際はクラウド・ベ―スの出荷プロセス管理ソフトウエア「クリオポ―タル」を利用。本社はカリフォルニア州レイクフォレスト。 Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through its family of companies, Cryoport Systems, MVE Biological Solutions, CRYOPDP and Cryogene, Cryoport provides strategic solutions that will support the growing needs of these markets. The Company mission is to support life and health on earth through our advanced technologies, global supply chain network and dedicated scientists, technicians and supporting teams of professionals. Cryoport serves clients in life sciences research, clinical trials, and product commercialization. The Company supports the creation of life, the sustaining of life and life-saving advanced cell and gene therapies in over 100 countries around the world. |
| 本社所在地 | 20382 Barents Sea Circle Lake Forest CA 92630 USA |
| 代表者氏名 | Jerrell W. Shelton Jerrell W. Shelton |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 949-232-1900 |
| 設立年月日 | 32994 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 36人 |
| url | www.cryoport.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cyrx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -7.78667 |
| 終値（lastsale） | 10.74 |
| 時価総額（marketcap） | 306838277.28 |
| 時価総額 | 時価総額（百万ドル） 317.98040 |
| 売上高 | 売上高（百万ドル） 14.97486 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 297.96926 |
| 当期純利益 | 当期純利益（百万ドル） -9.39495 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 CryoPort Inc revenues increased 54% to $8.7M. Net loss increased 41% to $5.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Sales and marketing - Balancing value increase of 46% to $2.9M (expense) Other Non Operating I/E increase from $0K to $899K (expense). |
CYRXのテクニカル分析
CYRXのニュース
Cryoport''s Drop Likely Isn''t Over Yet (NASDAQ:CYRX) 2023/02/09 12:54:30 Seeking Alpha
Cryoport has significantly underperformed the broader market over the past several months. See why I think a sell rating is appropriate for CYRX stock.
Cryoport: Differentiated Offering In The Life Sciences Value Chain (NASDAQ:CYRX) 2023/02/08 06:04:43 Seeking Alpha
Cryoport has been punished over the last 12 months amid a number of downside catalysts. Click here to read why we rate CYRX stock a Buy.
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies 2023/01/18 13:30:00 PR Newswire
Partnership to Provide Cell and Gene Industry Integrated Solution including Cryoport''s IntegriCell™ platform, and Supply Chain Services NASHVILLE, Tenn., Jan. 18, 2023 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a leading global provider of innovative…
Stock Of Cryoport Inc. (NASDAQ: CYRX) Dropped By -13.55 Percent Over The Past Month, Is There Room For Downside? 2022/12/24 20:00:00 Marketing Sentinel
Cryoport Inc. (NASDAQ:CYRX)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $16.40, to imply a decrease of -4.76% or -$0.82 in intraday trading. The CYRX share’s 52-week high remains $60.36, putting it -268.05% down since that peak … Stock Of Cryoport Inc. (NASDAQ: CYRX) Dropped By -13.55 Percent Over The Past Month, Is There Room For Downside? Read More »
Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference 2022/12/20 13:30:00 PR Newswire
NASHVILLE, Tenn., Dec. 20, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that Jerrell Shelton, the Company''s Chief Executive Officer, will…
Stock Of Cryoport Inc. (NASDAQ: CYRX) Dropped By -13.55 Percent Over The Past Month, Is There Room For Downside? 2022/12/24 20:00:00 Marketing Sentinel
Cryoport Inc. (NASDAQ:CYRX)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $16.40, to imply a decrease of -4.76% or -$0.82 in intraday trading. The CYRX share’s 52-week high remains $60.36, putting it -268.05% down since that peak … Stock Of Cryoport Inc. (NASDAQ: CYRX) Dropped By -13.55 Percent Over The Past Month, Is There Room For Downside? Read More »
Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference 2022/12/20 13:30:00 PR Newswire
NASHVILLE, Tenn., Dec. 20, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that Jerrell Shelton, the Company''s Chief Executive Officer, will…
CryoPort PT Lowered to $30 at KeyBanc 2022/12/08 06:11:18 Investing.com
https://www.investing.com/news/pro/cryoport-pt-lowered-to-30-at-keybanc-432SI-2959705
Cryoport Inc. (NASDAQ: CYRX) Shares Fall By 6.05 Percent In The Past Week, But How Long Will It Last? 2022/12/03 18:00:00 Marketing Sentinel
Cryoport Inc. (NASDAQ:CYRX)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $19.99, to imply an increase of 0.55% or $0.11 in intraday trading. The CYRX share’s 52-week high remains $70.90, putting it -254.68% down since that peak … Cryoport Inc. (NASDAQ: CYRX) Shares Fall By 6.05 Percent In The Past Week, But How Long Will It Last? Read More »
Cryoport: The Golden Stock 2022/11/16 14:54:12 Seeking Alpha
Despite macroeconomic concerns, Cryoport is still generating a 7% revenue growth for the quarter. Learn why I maintain my buy recommendation on Cryoport with a 5/5 stars rating.
Cryoport''s New Prague facility returns to full production after fire 2022/03/30 21:32:46 Seeking Alpha
Cryoport (CYRX) on Wednesday said its New Prague facility returned to full production.A fire occurred in a portion of the CYRX unit MVE Biological Solutions manufacturing facility in…
Cryoport launches $100M stock repurchase program (NASDAQ:CYRX) 2022/03/14 05:40:14 Seeking Alpha
Cryoport''s (CYRX) board has unanimously authorized a repurchase program, under which Cryoport may repurchase up to $100M of its outstanding common stock and/or convertible senior…
CryoPort Approves $100M Buyback Program 2022/03/11 20:56:11 Benzinga
CryoPort Inc''s (NASDAQ: CYRX ) Board has authorized a repurchase program . Per the program, CryoPort may repurchase up to $100 million of its outstanding common stock and/or convertible senior notes. The repurchase program … Full story available on Benzinga.com